Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
published : This week sector : Health technology save search
Madrigal Statement on the Passing of Dr. Stephen Harrison
Published: 2024-04-24 (Just crawled : 20:00) - globenewswire.com
MDGL | $204.51 -6.35% -6.78% 580K
|
Health Technology
| Email alert
Add to watchlist
Freeline to Present New Data on its Gaucher and Parkinson’s Disease Programs at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting
Published: 2024-04-24 (Just crawled : 20:00) - globenewswire.com
FRLN | $6.48 0.0% 0
|
Health Technology
| Email alert
Add to watchlist
disease cell meeting parkinson’s therapy
Kronos Bio to Present Clinical Update on Phase 1/2 Trial of KB-0742 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Published: 2024-04-24 (Just crawled : 20:00) - globenewswire.com
KRON | $0.9644 1.52% 1.49% 880K
|
Health Technology
| Email alert
Add to watchlist
kb-0742 update meeting trial
FibroGen Announces Clinical Data from Dose Escalation Phase 1b Study of FG-3246 (FOR46) in Combination with Enzalutamide in Patients with Metastatic Castration Resistant Prostate Cancer will be Presented at the 2024 American Society of Clinical Oncology Annual Meeting
Published: 2024-04-24 (Just crawled : 20:00) - globenewswire.com
FGEN | $0.9844 -8.0% -8.7% 2.2M
|
Health Technology
| Email alert
Add to watchlist
fg-3246 cancer meeting study
ClearPoint Neuro Announces Initiation of Limited Market Release for the SmartFrame OR™ Stereotactic System
Published: 2024-04-24 (Just crawled : 20:00) - globenewswire.com
CLPT | $5.33 -3.09% -3.19% 59K
|
Health Technology
| Email alert
Add to watchlist
system for market
Corbus Pharmaceuticals Announces Abstract Accepted for Presentation at 2024 ASCO Annual Meeting
Published: 2024-04-24 (Just crawled : 20:00) - globenewswire.com
CRBP | $35.5 -5.94% -6.37% 220K
|
Health Technology
| Email alert
Add to watchlist
presentation asco pharmaceuticals for meeting
Predictive Oncology Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Published: 2024-04-24 (Just crawled : 20:00) - globenewswire.com
POAI | $1.34 3.88% 3.73% 24K
|
Health Technology
| Email alert
Add to watchlist
presentation for meeting
Jazz Pharmaceuticals to Present Data Across Growing Oncology Pipeline and Portfolio at ASCO 2024
Published: 2024-04-24 (Just crawled : 20:00) - prnewswire.com
BEIGF | $14.29 -9.87% 2.1K
|
n/a
| Email alert
Add to watchlist
FNCTF | News | $11.16 -20.84% 130
|
Communications
| Email alert
Add to watchlist
JAZZ | $108.38 -1.18% -1.19% 400K
|
Health Technology
| Email alert
Add to watchlist
BGNE | $144.0 3.61% 3.48% 220K
|
Health Technology
| Email alert
Add to watchlist
asco pipeline pharmaceuticals growing
Dynavax to Report First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024
Published: 2024-04-24 (Just crawled : 20:00) - prnewswire.com
DVAX | $11.42 -2.89% 810K
|
Health Technology
| Email alert
Add to watchlist
first conference report financial results
Viking Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
Published: 2024-04-24 (Just crawled : 20:00) - prnewswire.com
VKTX | $65.03 0.15% 0.15% 2.5M
|
Health Technology
| Email alert
Add to watchlist
LGND | $70.87 1.4% 1.38% 150K
|
Health Technology
| Email alert
Add to watchlist
first update therapeutics financial results
Cidara Therapeutics Announces Divestiture of Rezafungin to Mundipharma* to Focus on Advancing the Clinical Development of Cloudbreak DFC Pipeline
Published: 2024-04-24 (Just crawled : 20:00) - globenewswire.com
CDTX | News | $11.94 16.49% 14.15% 170K
|
Health Technology
| Email alert
Add to watchlist
cloudbreak rezafungin pipeline therapeutics development
Intra-Cellular Therapies Announces Closing of $575 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Published: 2024-04-24 (Just crawled : 20:00) - globenewswire.com
ITCI 4 d | $73.02 -1.34% -1.36% 730K
|
Health Technology
| Email alert
Add to watchlist
MS | News 0 d | $93.85 0.1% 0.0% 4.8M
|
Finance
| Email alert
Add to watchlist
million offering
Venus Concept Announces Loan Purchase and Completion of First Phase of Refinancing
Published: 2024-04-24 (Just crawled : 20:00) - globenewswire.com
VERO | $0.76 0.0% 8.1K
|
Health Technology
| Email alert
Add to watchlist
first
Cytokinetics to Announce First Quarter Results on May 8, 2024
Published: 2024-04-24 (Just crawled : 20:00) - globenewswire.com
CYTK | $66.76 1.82% 1.78% 780K
|
Health Technology
| Email alert
Add to watchlist
first results
Precigen to Present Late-breaking Abstract for Pivotal Phase 2 Study Data for PRGN-2012 AdenoVerse Immunotherapy for the Treatment of Patients with Recurrent Respiratory Papillomatosis at the 2024 ASCO Annual Meeting
Published: 2024-04-24 (Crawled : 19:00) - biospace.com/
PGEN | $1.42 1.43% 1.41% 560K
|
Health Technology
|
| O: -0.36%
H: 0.0%
C: 0.0%
prgn-2012 respiratory asco treatment immunotherapy for meeting study
Results of Novocure’s METIS Phase 3 Clinical Trial for Patients with Brain Metastasis from Non-Small Cell Lung Cancer to be Presented as Late-Breaking Abstract at ASCO 2024
Published: 2024-04-24 (Crawled : 19:00) - biospace.com/
NVCR | $12.35 2.45% 2.39% 1.1M
|
Health Technology
| Email alert
Add to watchlist
lung asco cancer cell for trial results
NanoVibronix to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024
Published: 2024-04-24 (Crawled : 18:00) - biospace.com/
NAOV 4 | $0.77 -5.68% 8.6K
|
Health Technology
| Email alert
Add to watchlist
microcap
Amarin Applauds HealthyWomen’s Citizen’s Petition Urging FDA To Take Further Action On Fenofibrate Prescribing in Patients at Risk of Cardiovascular Event
Published: 2024-04-24 (Crawled : 18:00) - globenewswire.com
AMRN | News | $0.8844 0.13% 0.12% 660K
|
Health Technology
| Email alert
Add to watchlist
fda risk cardiovascular
SpringWorks Therapeutics Announces Abstracts Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Published: 2024-04-24 (Crawled : 17:00) - globenewswire.com
SWTX | $43.37 -1.43% -1.45% 470K
|
Health Technology
|
| O: 0.55%
H: 0.0%
C: 0.0%
presentation for meeting therapeutics
First Approval for Rare Pediatric Cancer; New OTC Opioid Overdose Option
Published: 2024-04-24 (Crawled : 16:00) - biospace.com/
ABT | News | $106.9 -0.64% 0.0% 5.1M
|
Health Technology
|
| O: -1.04%
H: 0.0%
C: 0.0%
PRGO | $31.23 2.43% 0.0% 960K
|
Health Technology
|
| O: 0.1%
H: 0.0%
C: 0.0%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -1.02%
H: 0.0%
C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
rare first opioid approval for
Gainers vs Losers
| 65% | 35% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 210M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
ILAG | $0.51 6.03% 29.06% 430K
|
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.